Cardiac inotropy and cardiac calcium sensitization of PanLN800(-Forte), a cationic heptamethine indocyanine fluorescent contrast agent for intraoperative pan lymph node imaging
PanLN800(-Forte) is not a viable fluorescent contrast agent for lymph node imaging in surgery because of cardiac calcium sensitization but may be a novel treatment for heart failure.
Authors
- Victor M. Baart (ORCID: https://orcid.org/0000-0003-3583-7428)
- Taryn L. March
- Martin Pool (ORCID: https://orcid.org/0000-0002-4892-3109)
- Robin A. Faber
- Stefan Harmsen (ORCID: https://orcid.org/0000-0001-5812-7299)
- Mark W. Bordo
- Alexander L. Vahrmeijer (ORCID: https://orcid.org/0000-0001-9370-0011)
- A. Rob P.M. Valentijn
- Jacobus Burggraaf (ORCID: https://orcid.org/0000-0001-7912-0918)
- John V. Frangioni
Institutions
- Leiden University Medical Center (NL)
- Centre for Human Drug Research (NL)
- Curadel (United States) (US)
Publication Details
- Journal
- Toxicology and Applied Pharmacology
- Published
- 2024-12-30
- DOI
- https://doi.org/10.1016/j.taap.2024.117222
- Primary Topic
- Esophageal Cancer Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Case Western Reserve University
- School of Medicine, Case Western Reserve University